Advertisement
Screener

Vaxart, Inc. (VXRT) Graph

VXRT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $27.18M; Revenue including tax (m); Cost of revenue (m); Research and development $33.75M.
  • 2026-03-31: Revenue $39.23M; Revenue including tax (m); Cost of revenue (m); Research and development $29.41M.
  • 2025-09-30: Revenue $72.41M; Revenue including tax (m); Cost of revenue (m); Research and development $75.95M.
  • 2025-06-30: Revenue $39.73M; Revenue including tax (m); Cost of revenue (m); Research and development $49.73M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VXRT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Collaboration Revenue$2.92MNon CashRoyalty Revenue$11.00KRevenue$27.18MOperating expenses$40.36MOperating income-$13.17MOther income, net-$333.00KResearch & development$33.75MPre-tax income-$13.46MIncome tax$29.00KNet income-$13.49M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$27.18M(m)(m)$33.75M(m)$40.36M$29.00K-$13.49M
2026-03-31$39.23M(m)(m)$29.41M(m)$34.05M$29.00K$5.18M
2025-09-30$72.41M(m)(m)$75.95M(m)$80.22M$17.00K-$8.14M
2025-06-30$39.73M(m)(m)$49.73M(m)$54.33M$20.00K-$14.99M
2025-03-31$20.88M(m)(m)$30.74M(m)$35.81M$95.00K-$15.59M
2024-09-30$4.93M(m)(m)$15.07M(m)$19.41M$18.00K-$14.08M
2024-06-30$6.40M(m)(m)$17.48M(m)$22.66M$21.00K-$16.47M
2024-03-31$2.18M(m)(m)$19.01M(m)$26.25M$45.00K-$24.42M
2023-12-31(m)$3.25M*(m)(m)(m)(m)(m)(m)
2023-09-30$2.10M$2.10M(m)$15.00M(m)$19.92M$39.00K-$17.40M
2023-06-30$1.36M$1.36M(m)$18.81M(m)$24.41M$19.00K-$22.55M
2023-03-31$675.00K$675.00K(m)$19.62M(m)$26.25M$29.00K-$25.14M
2022-09-30(m)$0.00(m)$22.47M(m)$29.43M$16.00K-$29.31M
2022-06-30(m)$0.00(m)$19.93M(m)$29.25M$15.00K-$29.43M
2022-03-31(m)$85.00K(m)$18.20M(m)$24.86M$20.00K-$25.10M
2021-12-31(m)$74.00K(m)(m)(m)$24.29M(m)-$20.76M
2021-09-30(m)$200.00K(m)$12.41M(m)$17.45M$21.00K-$17.58M
2021-06-30(m)$112.00K(m)$10.74M(m)$15.89M$30.00K-$16.12M
2021-03-31(m)$506.00K(m)$10.07M(m)$16.02M$38.00K-$16.01M
2020-12-31(m)$356.00K(m)(m)(m)$13.72M(m)-$13.86M
2020-09-30(m)$265.00K(m)$4.62M(m)$7.85M$26.00K-$8.09M
2020-06-30(m)$523.00K(m)$5.11M(m)$9.05M$26.00K-$8.98M
2020-03-31(m)$2.90M(m)$1.54M(m)$3.60M$153.00K-$1.30M
2019-12-31(m)$3.92M(m)(m)(m)$9.54M(m)-$6.41M
2019-09-30(m)$454.00K(m)$3.71M(m)$5.17M$31.00K-$5.26M
2019-06-30(m)$85.00K(m)$3.71M(m)$5.08M$13.00K-$5.64M
2019-03-31$5.41M$5.41M(m)$3.83M(m)$5.86M$250.00K-$1.34M
2018-12-31$1.77M$1.77M(m)(m)(m)$5.95M(m)-$4.90M
2018-09-30$281.00K$281.00K(m)$4.38M(m)$6.16M(m)-$6.55M
2018-06-30$608.00K$608.00K(m)$5.01M(m)$8.38M$1.00K-$8.87M
2018-03-31$1.50M$1.50M(m)$3.41M$2.01M$5.42M$28.00K$2.31M
2017-12-31$760.00K(m)(m)$2.50M(m)$3.45M$100.00K-$1.07M
2017-09-30$915.00K(m)(m)$2.25M(m)$2.87M(m)-$2.17M
2017-06-30$1.85M(m)(m)$4.32M(m)$4.98M$0.00*-$3.54M
2017-03-31$2.31M(m)(m)$3.88M$678.00K$4.56M$200.00K-$2.80M
2016-12-31$3.80M(m)(m)$10.20M(m)(m)$100.00K-$9.10M
2016-09-30$100.00K(m)(m)$7.60M(m)(m)(m)-$10.00M
2016-06-30$600.00K(m)$7.40M(m)(m)(m)(m)-$7.10M
2016-03-31$5.30M(m)$10.50M$8.50M(m)(m)(m)-$5.20M
2015-12-31$1.70M(m)$8.20M$6.30M(m)(m)(m)-$6.50M
2015-09-30$1.70M(m)$8.40M$5.50M(m)(m)(m)-$6.60M
2015-06-30$4.10M(m)$24.10M(m)(m)(m)(m)-$19.90M
2015-03-31$5.90M(m)$4.80M$4.80M(m)(m)(m)$1.20M
2014-12-31$13.90M(m)$7.50M$4.80M(m)(m)(m)$6.50M
2014-09-30$700.00K(m)$7.70M$4.90M(m)(m)(m)-$6.90M
2014-06-30$8.50M(m)$19.00M(m)(m)(m)(m)-$10.20M
2014-03-31$29.50M(m)$26.30M$4.10M(m)(m)(m)$3.20M
2013-12-31$18.50M(m)$18.60M$4.20M(m)(m)(m)-$100.00K
2013-09-30$12.20M(m)$16.30M$3.00M(m)(m)-$100.00K-$3.90M
2013-06-30$9.30M(m)$7.70M(m)(m)(m)(m)-$6.50M
2013-03-31$12.50M(m)$4.10M$4.50M(m)(m)-$12.00K$200.00K
2012-12-31$10.40M(m)$7.10M$4.60M(m)(m)-$6.00K$4.60M
2012-09-30$1.40M(m)$1.50M$4.60M(m)$4.75M-$100.00K-$7.20M
2012-06-30$631.00K(m)(m)$1.33M(m)$3.51M(m)-$2.73M
2012-03-31$7.09M(m)(m)$5.71M(m)$2.79M$146.00K-$2.04M
2011-12-31$2.09M(m)(m)$5.73M(m)$2.84M*-$520.00K-$7.05M
2011-09-24$1.09M(m)(m)$4.39M(m)$6.02M-$2.02M$78.00K
2011-06-25$3.74M(m)(m)$6.46M(m)$8.43M(m)-$4.60M
2011-03-26$9.17M(m)(m)$5.33M(m)$7.30M(m)$1.98M
2010-09-25$12.34M(m)(m)$6.80M(m)$9.06M-$1.76M$5.13M
2010-06-26$4.85M(m)(m)$6.53M(m)(m)(m)-$3.41M

Revenue and expense 6 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30$66.41M(m)$63.17M$74.41M$58.00K-$8.31M
2025-06-30$60.61M(m)$80.48M$90.14M$115.00K-$30.58M
2024-06-30$8.58M(m)$36.49M$48.91M$66.00K-$40.88M
2023-06-30$2.03M$2.03M$38.44M$50.66M$48.00K-$47.69M
2022-06-30(m)$85.00K$38.13M$54.11M$35.00K-$54.53M
2021-06-30(m)$618.00K$20.81M$31.90M$68.00K-$32.12M
2020-06-30(m)$3.42M$6.66M$12.64M$179.00K-$10.27M
2019-06-30(m)$5.49M$7.54M$10.94M$263.00K-$6.98M
2018-06-30$2.11M$2.11M$8.42M$13.80M$29.00K-$6.56M
2017-12-31$2.80M(m)$5.30M(m)$100.00K-$8.70M
2017-06-30$4.16M(m)$8.20M(m)(m)-$6.33M
2016-12-31$3.90M(m)$17.80M(m)$100.00K-$19.10M
2015-12-31$3.40M(m)$11.80M(m)(m)-$13.20M
2014-12-31$14.60M(m)$9.70M(m)(m)-$400.00K
2013-12-31$30.80M(m)$7.10M(m)-$100.00K-$4.00M
2012-12-31$11.80M(m)$9.10M(m)-$100.00K-$2.60M
2012-06-30$1.26M(m)$2.85M$6.30M-$671.00K-$3.17M
2011-12-31$6.24M(m)$12.06M(m)-$650.00K-$11.25M
2011-06-25$12.92M(m)$11.79M$15.73M(m)-$2.62M
2010-06-26$18.59M(m)$12.44M(m)(m)$2.07M

Revenue and expense 9 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2025-09-30$133.02M(m)$156.43M$170.37M$132.00K-$38.72M
2024-09-30$13.52M(m)$51.56M$68.32M$84.00K-$54.96M
2023-09-30$4.13M$4.13M$53.44M$70.58M$87.00K-$65.09M
2022-09-30(m)$85.00K$60.59M$83.53M$51.00K-$83.84M
2021-09-30(m)$818.00K$33.22M$49.35M$89.00K-$49.71M
2020-09-30(m)$3.69M$11.27M$20.50M$205.00K-$18.36M
2019-09-30(m)$5.95M$11.25M$16.11M$294.00K-$12.24M
2018-09-30$2.39M$2.39M$12.80M$19.96M$29.00K-$13.11M
2017-09-30$5.08M(m)$10.45M(m)(m)-$8.51M
2017-03-31$8.80M(m)$24.60M(m)$300.00K-$23.50M
2016-03-31$8.80M(m)$20.40M(m)(m)-$18.40M
2015-03-31$20.50M(m)$14.50M(m)(m)$800.00K
2014-03-31$60.30M(m)$11.30M(m)-$100.00K-$800.00K
2013-03-31$24.30M(m)$13.60M(m)-$100.00K-$2.40M
2012-09-30$1.90M(m)$5.99M$11.05M-$671.00K-$7.26M
2012-03-31$13.33M(m)$17.77M(m)-$504.00K-$13.29M
2011-09-24$14.00M(m)$16.18M$21.76M-$2.02M-$2.54M
2010-09-25$30.93M(m)$19.24M$25.74M-$1.76M$7.21M

Revenue and expense 12 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2025-12-31$237.26M(m)$201.58M$219.18M$476.00K$16.33K
2024-12-31$28.70M(m)$74.21M$94.99M$260.00K-$66.95K
2023-12-31$7.38M$7.38M$68.14M$90.73M$261.00K-$82.47K
2022-12-31(m)$107.00K$81.05M$114.69M$67.00K-$107.76M
2021-12-31(m)$892.00K$48.75M$73.64M$107.00K-$70.47M
2020-12-31(m)$4.05M$19.86M$34.22M$238.00K-$32.22M
2019-12-31(m)$9.86M$14.54M$25.65M$490.00K-$18.64M
2018-12-31$4.16M$4.16M$17.27M$25.91M$109.00K-$18.01M
2017-12-31$5.84M(m)$12.36M(m)(m)-$9.58M
2017-06-30$8.90M(m)$28.30M(m)$300.00K-$29.40M
2016-06-30$9.30M(m)$26.30M(m)(m)-$25.40M
2015-06-30$24.60M(m)$19.80M(m)-$100.00K-$19.10M
2014-06-30$68.70M(m)$17.50M(m)-$300.00K-$11.00M
2013-06-30$33.60M(m)$19.90M(m)$100.00K-$8.90M
2012-06-30$20.40M(m)$24.10M(m)-$500.00K-$19.20M
2011-12-31$14.84M(m)$17.77M$24.60M-$2.02M-$4.53M
2011-06-30$12.50M(m)$33.50M(m)-$800.00K-$25.40M
2010-12-25$35.01M(m)$26.08M$36.20M-$1.76M$878.00K
2009-12-26$10.49M(m)$16.49M$28.46M(m)-$18.73M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B